TRAP Study: Testosterone for Androgen Receptor Polymorphism
Status:
Not yet recruiting
Trial end date:
2025-03-31
Target enrollment:
Participant gender:
Summary
To determine whether pretreatment with transdermal testosterone increases the number of
cumulus-oocyte complexes (COCs) obtained after ovarian stimulation by more than 1.5 in
patients with low ovarian reserve and androgen receptor polymorphism undergoing
intracytoplasmic sperm injection (ICSI).